Inhibition of prion propagation by receptor associated protein (RAP), its derivatives, mimetics and synthetic peptides
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 9, 2015
Grant Date -
May 31, 2012
app pub date -
May 17, 2010
filing date -
May 21, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A pharmaceutical formulation and method of treatment of prion disease include a RAP agent with a pharmaceutically acceptable carrier and/or excipient, and the administration of same to a subject suffering from or at risk of a prion disease. The RAP agent is an effective means for the prevention and/or treatment of various prion diseases regardless whether the disease is acquired by infection or by genetic mutation.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully